首页> 外文OA文献 >Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase

【2h】

Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase

机译：将动态正电子发射断层扫描和常规药代动力学研究整合到副血浆和肿瘤药代动力学，由胸苷合酶生物激活的前药

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jing Li; Seongho Kim; Anthony F. Shields; Kirk A. Douglas; Christopher I. McHugh; Jawana M. Lawhorn-Crews; Jianmei Wu; Thomas J. Mangner; Patricia M. LoRusso;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase [J] . Li Jing, Kim Seongho, Shields Anthony F., The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2016,第11期

机译：结合动态正电子发射断层扫描和常规药代动力学研究来描绘血浆和肿瘤药代动力学的FAU，一种由胸苷酸合酶生物激活的前药
2. Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase [J] . Li Jing, Kim Seongho, Shields Anthony F., The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2016,第11期

机译：将动态正电子发射断层扫描和常规药代动力学研究整合到替代血浆和肿瘤药代动力学，由胸苷合酶生物激活的前药
3. Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors. [J] . Ricart AD, Berlin JD, Papadopoulos KP, Clinical cancer research: an official journal of the American Association for Cancer Research . 2008,第23期

机译：一期，新型脂质体胸苷酸合酶抑制剂OSI-7904L和顺铂在实体瘤患者中的药代动力学和生物学相关性研究。
4. Assessing pharmacokinetics of indocyanine green-loaded nanoparticle in tumor with a dynamic diffuse fluorescence tomography system [C] . Yanqi Zhang, Guoyan Yin, Huijuan Zhao, Imaging, Manipulation, and Analysis of Biomolecules, Cells and Tissues XVI . 2018

机译：用动态扩散荧光层析成像系统评估吲哚菁绿纳米颗粒在肿瘤中的药代动力学
5. Evaluation of the pharmacokinetic-pharmacodynamic relationship, metabolism and plasma protein binding of the novel antitumor agent, 2-methoxyestradiol (2ME2), following oral administration in patients with solid tumors. [D] . Lakhani, Nehal Jagdish. 2005

机译：实体瘤患者口服后评估新型抗肿瘤药2-甲氧基雌二醇（2ME2）的药代动力学与药效关系，代谢和血浆蛋白结合。
6. Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU a Prodrug Bioactivated by Thymidylate Synthase [O] . Jing Li, Seongho Kim, Anthony F. Shields, -1

机译：结合动态正电子发射断层扫描和常规药代动力学研究来描述血浆和肿瘤药代动力学的FAU一种由胸苷酸合酶生物激活的前药
7. A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of 11C- and 14C-labelled verapamil in healthy volunteers [O] . Claudia C Wagner, Marie Simpson, Graham Lappin, 2008

机译：联合加速器质谱/正电子发射断层扫描微剂量研究评估健康志愿者中11C和14C标记的维拉帕米的血浆和脑组织药代动力学

Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase

著录项

相似文献

相关主题

期刊订阅